It has been reported that uridine shows depressant effects toward the central nervous system (CNS). For instance, uridine decreased spontaneous activity in mice and showed protection against seizures caused by penicillin or metrazol. 1, 2) In addition, uridine was extracted from the brainstems of 24 h sleep-deprived rats 3) and caused natural sleep following nocturnal infusion into the rat brain. 4, 5) However, uridine itself does not possess any hypnotic activity, as determined by loss of the righting reflex in experimental animals. In 1985, it was demonstrated that N 3 -benzyluridine exerts hypnotic activity on mice by intracerebroventicular (i.c.v.) administration, 6) and the structure-activity relationship has been further explored.
In addition, uridine was extracted from the brainstems of 24 h sleep-deprived rats 3) and caused natural sleep following nocturnal infusion into the rat brain. 4, 5) However, uridine itself does not possess any hypnotic activity, as determined by loss of the righting reflex in experimental animals. In 1985, it was demonstrated that N 3 -benzyluridine exerts hypnotic activity on mice by intracerebroventicular (i.c.v.) administration, 6 ) and the structure-activity relationship has been further explored. [7] [8] [9] It became clear that the introduction of methylbenzyl, as well as a benzyl group, at N 3 of uridine is effective in producing CNS depressant effects.
7b,c) Trials to modify the sugar showed a diminished effect, 7b,e-g) except for N 3 -substituted thymidine 7d) and arabinofuranosyluracil.
7h) It has been proven that N 3 -phenacyluridine strongly intensifies the sleep induced by pentobarbital (PB) or diazepam. 8a,b) Although N 1 -allyl-5,6-substituted 2-thiouracil derivatives have been synthesized and evaluated in terms of sedative-hypnotic activity, 9) no report concerning N 3 -substituted 4-thiouridines has appeared. Barbiturates have been in use as a sedative hypnotic since 1903, and 2-thiobarbituric acids (2-thioxohexahydropyrimidine-4,6-dione) continue to be used as short-acting barbiturates. This background prompted us to explore the 4-thio analogues of N 3 -substituted uridine. In this paper, we wish to report the synthesis and CNS-depressant effect of N 3 -substituted 4-thiouridines (5a-d). Synthesis Tri-O-acetyl derivatives of N 3 -benzyluridine (2a) and N 3 -phenacyluridine (2c) were prepared by the nucleophilic displacement of 2Ј,3Ј,5Ј-tri-O-acetyluridine (1) with benzyl bromide or 2-chloroacetophenone in the presence of K 2 CO 3 in N,N-dimethylformamide (DMF), according to the published method. 7a,8a) In the case of 2d, condensation of 1 with 3,5-dimethylbenzyl alcohol using diisopropyl azodicarboxylate and tributylphosphine was employed, 10) since aralkyl halide was not commercially obtainable. Also, (Ϯ)-1-phenylethanol was similarly reacted with 1 to give a 1-phenylethyl derivative (2b) as a mixture of diastereomers. Compound 2d was deprotected by treatment with ammonia in MeOH to give 3d. Next, the synthesis of N 3 -substituted 4-thiouridines was explored as follows. Methods concerning the thiation of uracil or uridine have been universally reported. However, the introduction of an alkyl group on N 3 of 4-thiouridine has been difficult because 4-alkylthio derivatives were inevitably formed. 11) Recently, 3-alkyluracils were successfully converted to the 4-thio congener by Lawesson's reagent.
12) We adopted this method for the synthesis of compounds 5a-d. Thus, compound 2a was refluxed with Lawesson's reagent in benzene to give 4a in 52% yield, and subsequent treatment of the product with ammonia in MeOH gave N 3 -benzyl-4-thiouridine 5a, which showed an absorption maximum at 330 nm on UV. 13) In a similar manner, compounds 5b-d were prepared from the corresponding N 3 -substituted tri-O-acetyluridine (2b-d). To confirm the site of alkylation, the most biologically active compound, 5c, was subjected to heteronuclear multiple bond connectivity (HMBC) study. As shown in Fig. 1 , this compound was demonstrated to be the 3-phenacyl analogue, since correlation between the methylene protons of the phenacyl group and C(4) as well as C(2) was observed.
Pharmacological Results
The hypnotic activities of the N 3 -substituted 4-thiouridine were assayed according to previously established procedures, 7) and the results are presented in Table 1 and Fig. 2 . By comparison with the earlier result of N 3 -benzyluridine (3a, 36Ϯ2 min), 7b) 4-thio congener (5a) exhibited better hypnotic activity (84Ϯ10 min) when administered to mice by i.c.v. injection at 2.0 mmol/mouse. This is the first demonstration that N 3 -substituted 4-thiouridine has CNS-depressant activity. In contrast, 5a reduced a prolongation of PB-induced sleep by 24% compared with 3a. In the series of N 3 -(1-phenylethyl) derivatives, it was reported that a uracil congener (3b) caused only 7 min sleep at the same dosage. However, the 4-thiouridine derivative (5b) showed moderate hypnotic activity (58Ϯ15 min). The PB-induced sleep-promoting activity of 5b was similar to that 3b.
7b) These results indicate that N 3 -benzyl (5a) or the N 3 -(1-phenylethyl) derivative (5b) of 4-thiouracil show enhanced hypnotic activity and decreased PB-induced sleep-promoting activity compared to the corresponding uracil congener (3a, b). Although 5c showed the most potent hypnotic activity (96Ϯ19 min) among the 4-thio series, its activity was almost half that of 3c (184Ϯ13 min). It is indicated that the oxygen of the 4 position of the uracil ring is important in the hypnotic activity of 3c. However, 5c caused a prolongation of PB-induced sleep and its activity was more than 30% stronger compared with the reported data of 3c. 8a) Since N 3 -benzyluridines bearing a methyl group onto the benzene ring, i.e. o-, m-and p-methylbenzyl derivatives, have been proved to be better CNS-depressants than N 3 -benzyluridine (3a), 7b,c) the activity of N 3 -(3,5-dimethylbenzyl)uridine (3d) and its 4-thio congener (5d) was also examined. However, the hypnotic activity of 3d and 5d was poor, and 3d showed the weakest PB-induced sleep-prolonging activity in this series.
Synthesis and Hypnotic Activities of 4-Thio Analogues of N 3 -Substituted Uridines
In conclusion, N 3 -benzyl-(5a) or N 3 -(1-phenylethyl)-4-thiouridine (5b) enhanced hypnotic activity compared with the original compounds 3a and 5a, respectively. However, the strong hypnotic activity of N 3 -phenacyluridine (3c) was reduced to half by 4-thio modification, as shown in Table 1 . This tendency was reversed in the PB-induced sleep-prolonging activity. The PB-induced sleeping time of 5a was shorter than that of 3a, and 5c showed more prolongation than 3c. 
Experimental
Melting points (mp) were determined using a Yanagimoto micro-melting point apparatus (hot stage type) and are uncorrected. UV spectra were recorded with a Shimadzu UV-190 digital spectrometer. Low-resolution mass spectra were obtained on a Shimadzu-LKB 9000B mass spectrometer in the direct-inlet mode. .7 g, 10 mmol) in DMF (50 ml) was added potassium carbonate (1.04 g, 7.5 mmol) and benzyl bromide (1.62 ml, 15 mmol), and they were stirred at 50°C for 1 h; then acetic acid (0.9 ml) was added and the mixture was concentrated to a small volume. The residue was partitioned between CHCl 3 (50 ml) and water (50 ml). The organic layer was dried over MgSO 4 , and the residual solution was chromatographed over a column of Silica gel G (3.1ϫ40 cm) using 33-66% AcOEt in hexane (1 l) to give a caramel (3.8 g, 83% 
-(1-Phenylethyl)-2,3,5-tri-O-acetyluridine (2b). General Procedure for 2d
To a mixture of 1 (3.7 g, 10 mmol) and (Ϯ)-1-phenylethanol (2.4 ml, 20 mmol) in dry tetrahydrofuran (THF) (100 ml) was added triphenylphosphine (5.25 g, 20 mmol) and diisopropyl azodicarboxylate (4 ml, 20 mmol). The solution was stirred at 50°C for 6 h, then concentrated over a small volume. The residual solution was chromatographed over a column of Silica gel G (4.2ϫ30 cm) using 20-75% AcOEt in hexane (2 l) to give a caramel (2.86 g, 60%). 22 g, 60%) from 2c (1.95 g, 4 mmol) .
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